I am a 26 year old male having hbsag and hbeag=+ve,hbv dna =1070 iu/ml(Taqman) but my LFT results are normal(sgpt=37,sgot=33).My doctor has asked me to take lamivudine 100 mg for 6 months or until it becomes -ve.My mom is taking lamivudine for the last 7 months after her hbv dna crossed 8 lacs iu/ml.Probably I have been infected from my birth.Is it possible for both of us to completely cure Hep. B after taking lamivudine.
what happens if u took lamivudine for 3 months for fHbsAg (no HbeAg) then stopped for 2 months and your LFT got worst, do you start the drug and complete for 6 months? or what do you advice me to do?
I have tested positive to Hbsag for more than a year now. I was placed on lamivudine, methionine and essential forte. d doctor never ask me to do viral load test anytime I see him he do ask me to do LFT and subject me to d early medications I listed. so a friend advice me to go teaching hospital were I can see a specialist. my question here is now that I have been on medication for a year without knowing my viral load what is d implication ?
One of the three patients was participating in a famciclovir trial and the other two were receiving lamivudine therapy for active hepatitis B infection. All three patients had documented hepatitis B flares, and all had hepatitis B virus DNA detected at that time. All patients developed decompensated liver disease despite one patient having had a prior liver biopsy showing absence of cirrhosis.
stop lamivudine immediately or switch to tenofovir, it is decades now lamivudine is not used because it can lead to cytopatic hbv mutations that cannot be control with any medication leading to cancer and cirrhosis despite hbsag negative, hbvdna undetectable and normal ast-alt, another reason not to use lamivudine is that it is even totally useless on hbv
the hbsag of the virus mutates to a form where the virus destroy cells directly even without replication
hbv cure is achieved only by sequen
The study sampled 1,000 physicians, including internists, primary care providers, and gastroenterologists to determine this group’s knowledge about hepatitis B, and their capability to effectively assess patients’ risk for hepatitis B and immunize and screen them.
Researchers created a survey featuring four fictional case histories that described patients at high risk for contracting HBV, followed by questions regarding knowledge, attitudes, and beliefs of HBV screening and vaccination.
http://archive.mail-list.com/hbv_research/message/20111218.203256.018c61a9.en.html
Author: [email protected]
Date: 2011-12-18 21:32 +100
To: hbv_research
Subject: Lamivudine resistance mutations in patients with genotype D
World J Gastroenterol. 2011 Dec 7;17(45):4987-92.
Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D.
Source: http://www.ncbi.nlm.nih.
Conclusions
The rate of response to sequential therapy with entecavir and interferon-α in Japanese patients with HBeAg-positive chronic hepatitis B was not higher than the rate in previous studies of lamivudine followed by interfero
Please I was diagnosed with positive hepatitis b antigen last month. My doctor prescribed Lamivudine 100 mg once daily for three months. Pls advice can I continue with the drug.
About one year ago when I conducted Hepatitis B profile, I had NON RELICATIVE INFECTION but about one year on lamivudine I am now REPLICATIVE. Please what does this suggest? I am planning to stop taking lamivudine because it gives me so much side effect ranging from stomach discomforts and back pains and general weakness. The doctor I met this time related all these complaints to lamivudine.
I have chronical Hepatitis B, started with 52.000.000 IU/ml in November 2010. After using the Robert C. Becks Protocol my viral load went down to 42.000.000 IU/ml in one month (about - 17%), but after that it went to over 110.000.000 IU/ml. I am using Rober C. Beck's Protocol (Blood Electrification+Magnetic Pulsing+Collodial Silver+Ozonate Watter) for 7 months. I feel better than ever before. I am doing work out twice a week and run about 10 km a week.
this might be a very good choice for those with kidneys problems or high creatinine
Antiviral Telbivudine Appears to Protect Kidney Health
The antiviral telbivudine (Tyzeka), may not be as potent as other hepatitis B antivirals, but it appears to have a unique quality—it appears to “protect” the kidneys against damage usually linked to antiviral treatment, according to an article in the December issue of the Journal of Viral Hepatitis.
It is well known that viral genotype has a major impact on response to interferon-based therapy for hepatitis C, but it is unclear whether this is also true for hepatitis B. In addition, the influence of race/ethnicity -- also a major determinant of the efficacy of hepatitis C treatment -- remains poorly defined for hepatitis B.
Recommended
